Influence of erythromycin on cyclosporine pharmacokinetics. 1987

P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008658 Inactivation, Metabolic Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion. Detoxication, Drug, Metabolic,Drug Detoxication, Metabolic,Metabolic Detoxication, Drug,Detoxification, Drug, Metabolic,Metabolic Detoxification, Drug,Metabolic Drug Inactivation,Detoxication, Drug Metabolic,Detoxication, Metabolic Drug,Detoxification, Drug Metabolic,Drug Inactivation, Metabolic,Drug Metabolic Detoxication,Drug Metabolic Detoxification,Inactivation, Metabolic Drug,Metabolic Drug Detoxication,Metabolic Inactivation
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint
November 1985, The New England journal of medicine,
P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint
September 1986, Annals of internal medicine,
P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint
June 1986, Transplantation,
P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint
March 1989, Journal of clinical pharmacology,
P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint
January 1986, Pediatric infectious disease,
P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint
October 1977, Journal of clinical pharmacology,
P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint
April 1988, Transplantation proceedings,
P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint
January 2009, Experimental diabetes research,
P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint
February 1996, Arzneimittel-Forschung,
P Vereerstraeten, and P Thiry, and P Kinnaert, and C Toussaint
January 1991, DICP : the annals of pharmacotherapy,
Copied contents to your clipboard!